Cytochrome P450 2D6 and glutathione S-transferase M1 genotypes and migraine

European Journal of Clinical Investigation

Volumn 30, Issue 4, 2000, Pages 367-371

  Mattsson, Peter ^a   Bjelfman, C ^a   Lundberg, P O ^a   Rane, A ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CYP2D6; Epidemiology; GSTM1; Migraine

Indexed keywords

CYTOCHROME P450 2D6; CYTOCHROME P450 ISOENZYME; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BRAIN METABOLISM; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; ALLELES; CYTOCHROME P-450 CYP2D6; DNA; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MIDDLE AGED; MIGRAINE DISORDERS; ODDS RATIO; POLYMORPHISM, GENETIC; REFERENCE VALUES;

EID: 0034052291     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00633.x     Document Type: Article

References (25)

1. 1 Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992;12:221-8.
2. 2 Goadsby PJ. Pathophysiology of migraine. A disease of the brain. In: Goadsby PJ, Silberstein SD, editors. Blue Books of Practical Neurology Headache Ist ed. Boston: Butterworth-Heinemann; 1997. p.5-24.
3. 3 Rowe JD, Nieves E, Listowsky I. Subunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antisera. Biochem J 1997;325:481-6.
4. 4 Pelkonen O, Raunio H. Metabolic activation of toxins: tissue-specific expression and metabolism in target organs. Environ Health Perspect 1997;105 (Suppl. 4):767-74.
5. 5 Broly F, Gaedigk A, Heim M, Eichelbaum M, Morike K, Meyer UA. Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population. DNA Cell Biol 1991;10:545-58.
6. 6 Gough AC, Miles JS, Spurr NK, Moss JE, Gaedigk A, Eichelbaum M et al. Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Nature 1990;347:773-6.
7. 7 Heim M, Meyer UA. Genotyping of poor metabolizers of debrisoquine by allel-specific PCR amplification. Lancet 1990;336:529-32.
8. 8 Alvan G, Bechtel P, Iselius L, Gundert Remy U. Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations. Eur J Clin Pharmacol 1990;39:533-7.
9. 9 Seidegård J, Vorachec WR, Pero RW, Pearson WR. Hereditary differences in the expression of human glutathione transferase activity on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988;85:7293-7.
10. 10 Brockmoller J, Kerb R, Drakoulis N, Staffeldt B, Roots I. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res 1994;54:4103-11.
11. 11 Heagerty A, Smith A, English J, Lear J, Perkins W et al. Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender. Br J Cancer 1996;73:44-8.
12. 12 Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993;14:1821-4.
13. 13 Dalton K. Food intake prior to a migraine attack-study of 2, 313 spontaneous attacks. Headache 1975;15:188-193.
14. 14 Leviton A. To what extent does food sensitivity contribute to headache recurrence? Dev Med Child Neurol 1984;26:539-45.
15. 15 Gibb C, Davies PT, Glover V, Steiner TJ, Rose FC, Sandler M. Chocolate is an migraine-provocing agent. Cephalalgia 1991;11:93-5.
16. 16 Moffett AM, Swash M, Scott DF. Effect of chocolate in migraine: a double-blind study. J Neurol Neurosurg Psychiatry 1974;37:445-8.
17. 17 Warner M, Gustavsson J-Å. Cytochrome P450 in the brain: neuroendocrine functions. Front Neuroendocrinol 1995;16:224-36.
18. 18 Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 (Suppl. 7):1-96.
19. 19 Thurfjell E. Mammography screening methods and diagnostic results. Thesis. Acta Radiol Suppl. 1995;395:1-22.
20. 20 Spurr NK, Gough AC, Smith CA, Wolf CR. Genetic analysis of the cytochrome P450 system. Methods-Enzymol 1991;206:149-66.
21. 21 Smith CA, Gough AC, Leigh PN, Summers BA, Harding AE et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375-7.
22. 22 Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research. Principles and Quantitative Methods. New York: Van Nostrand Reinhold; 1982.
23. 23 Dahlof C, Alm C, Bertling I, Barret L. Cytochrome P-450-dependent hydroxylation in migraine. Cephalalgia 1992;12:158-60.
24. 24 Amery WK, Davies PT, Caers LI, Heykants J, Steiner TJ, Woestenborghs R et al. Hepatic cytochrome P450-mediated oxidation function in migraine. Cephalalgia 1988;8:71-4.
25. 25 Perrett CW, Clayton RN, Pistorello M, Boscaro M, Scanarini M et al. GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on P53, ras and gsp. Carcinogenesis 1995;16:1643-5.